POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
| Brand name | POTASSIUM PHOSPHATES |
|---|---|
| Active ingredient | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC |
| Strength | 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | September 2019 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 10632150 | April 2039 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.